Literature DB >> 3059450

Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial.

C J Mulder1, G N Tytgat, E H Wiltink, H J Houthoff.   

Abstract

Twenty-nine patients with attacks of distal ulcerative colitis were treated randomly with 3 g 5-aminosalicylic acid (5-ASA) or 30 mg of prednisolone phosphate sodium (PP) enemas (40 ml). Endoscopic, clinical, and histologic improvement were comparable in the two treatment groups. Our study showed that topical treatment with 5-ASA is as efficacious as PP in improving distal ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3059450     DOI: 10.3109/00365528809090161

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Morphometric studies in rectal biopsy specimens from patients with ulcerative colitis: effect of oral 5 amino salicylic acid and rectal prednisolone treatment.

Authors:  A M Zaitoun; I Cobden; H al Mardini; C O Record
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

Review 2.  AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.

Authors:  Siddharth Singh; Joseph D Feuerstein; David G Binion; William J Tremaine
Journal:  Gastroenterology       Date:  2018-12-18       Impact factor: 22.682

Review 3.  AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.

Authors:  Cynthia W Ko; Siddharth Singh; Joseph D Feuerstein; Corinna Falck-Ytter; Yngve Falck-Ytter; Raymond K Cross
Journal:  Gastroenterology       Date:  2018-12-18       Impact factor: 22.682

4.  Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

Authors:  Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  Formulation and stability of a beclomethasone dipropionate enema.

Authors:  L M Stolk; M Gerrits; E H Wiltink; C J Mulder; G N Tytgat
Journal:  Pharm Weekbl Sci       Date:  1989-02-24

6.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

Authors:  J K Marshall; E J Irvine
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

7.  Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.

Authors:  D W Hommes; J Meenan; M de Haas; F J ten Kate; A E von dem Borne; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

8.  Retrograde spread of mesalazine (5-aminosalicylic acid)-containing enema in patients with ulcerative colitis.

Authors:  M M Tiel-van Buul; C J Mulder; E A van Royen; E H Wiltink; G N Tytgat
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

9.  Effects of local budesonide treatment on the cell-mediated immune response in acute and relapsing colitis in rats.

Authors:  M J Palmen; L A Dieleman; M Soesatyo; A S Peña; S G Meuwissen; E P van Rees
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.